Description of Collaborative Activity: |
NIAID established the Zika Vaccine Development Working Group, which includes representatives from various US Government agencies (BARDA, CDC, FDA) to coordinate research efforts, mobilization of domestic and international research infrastructure, and partnerships with industry to accelerate the development of a safe and effective Zika vaccine. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
